Job title: Assoc. Prof.
Institution: Perdana University School of Data Sciences
Google Scholar: https://scholar.google.com/citations?user=55on7_AAAAAJ&hl=en
Email: sybing.choi@perdanauniversity.edu.my, sybing@gmail.com
Address: Perdana University, Suite 9.2, 9th Floor, Wisma Chase Perdana, Changkat Semantan, Damansara Heights, 50490 Kuala Lumpur, Malaysia.
Research Interest
Structural Bioinformatics | Drug Discovery | Data Visualization | Healthcare Data Analytics
Organisational affiliations
Malaysia Bioinformatics Network (MyBioinfoNet) – Working Committee (Event Manager & Social Media)
MSMBM – University Representative
Education
PhD (Pharmaceutical Technology), 2010, Universiti Sains Malaysia
MSc Information Technology, 2002, Universiti Sains Malaysia
BSc Biochemistry (First Class), 2000, University of Malaya
Dr. Choi is the Chief Executive Officer of Alterquo Sdn. Bhd. and an Associate Professor at Perdana University. With a degree in Biochemistry from Universiti Malaya (UM), she pursued further studies with MSc in Information Technology and PhD in Pharmaceutical Technology from Universiti Sains Malaysia (USM). She was an awardee of USM Postgraduate Fellowship and JASSO scholarship during her studies. In addition, she was selected to participate in the Frontierlab@osakaU Scientific Empowerment Programme in Japan. Besides varied research experience, she was the facilitator for International Students from University California San Diego (United States), Osaka University (Japan), Indian Institute of Technology Delhi (India), Chulalongkorn University (Thailand) and many more prestigious universities around the world, under the PRAGMA programme. Prior to her appointment at Perdana University, she was a research scientist at the Natura of the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm) and a postdoctoral research fellow at the School of Industrial Technology, USM. Her expertise include protein structure prediction, membrane protein molecular dynamics simulation, and in silico high throughput screening, as well as structure and ligand-based drug discovery.